CAR T:

Norah Layla Sadek1, Bruno Almeida Costa1, Karthik Nath2

  • 1Department of Medicine, Mount Sinai Morningside and West, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

概括

化学抗原受体 (CAR) T细胞疗法对多发性骨髓瘤 (MM) 治疗具有前景,但面临副作用和复发等挑战. 研究旨在优化CAR T细胞疗法,以提高MM患者的疗效和安全性.